FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to biotechnology. A raw material is presented by milk, which has not been processed at a temperature of more than 55°C. The above raw material is extracted on cation-exchange resin with using a concentrated solution of sodium chloride. A solution of primary milk protein containing lactoferrin, lactoperoxidase and other foreign matters is produced. The solution of primary milk protein is purified on cation exchange resin balanced with acetate buffer in the concentration of 50 mM at pH from 4 to 9. An elution procedure is ensured with using acetate buffer solutions in the concentration of 50 mM with the different concentrations of the sodium chloride solution - from 0.02 to 1.5 M. A lactoferrin-containing fraction is collected. The fraction contains more than 95% pure lactoferrin and is substantially free from lipopolysaccharides, endotoxins and angiogenin and has an iron saturation level from 9% to 20%. The produced fraction is applicable to accelerate maturation of a newborn's gastrointestinal tract or to recover a post-gastroenteritis intestinal mucosa, to increase monocyte activity and to improve the cytotoxic function of killer cells, as an anti-inflammatory agent, to reduce expression of anti-inflammatory cytokines, to inhibit or eliminate bacteria, to treat the diseases associated with bacterial films, to prepare solutions or ointments for wound cleaning or eye care, and to treat infectious respiratory diseases.
EFFECT: method for producing lactoferrin, the lactoferrin-containing fraction and using it are presented.
15 cl, 4 tbl, 11 dwg
Title | Year | Author | Number |
---|---|---|---|
TECHNOLOGY OF EXPERIMENTAL SEPARATION OF HUMAN LACTOFERRIN | 2013 |
|
RU2554742C1 |
METHOD OF PRODUCING LACTOFERRIN | 2018 |
|
RU2717340C1 |
METHOD FOR PRODUCTION OF HIGHLY PURIFIED LACTOFERRIN AND LACTOPEROXIDASE FROM MILK, COLOSTRUM, AS WELL AS SOUR OR SWEET WHEY | 2019 |
|
RU2823928C2 |
APPLICATION OF BOVINE LACTOFERRIN FOR PREPARING MEDICINAL AGENT FOR BACTERIA GROWTH INHIBITION | 2006 |
|
RU2399380C2 |
COMPOSITIONS CONTAINING FETAL HEMOGLOBIN AND BACTERIAL ENDOTOXIN AND OPTIONALLY, FETAL LIVER ADDITIVE | 2004 |
|
RU2366449C2 |
METHOD FOR LACTOFERRIN ISOLATION AND PURIFICATION FROM DAIRY RAW MATERIALS | 2016 |
|
RU2634859C1 |
PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
METHOD OF SEPARATING LACTOFERRIN OF HUMAN AND GOAT BY MEANS OF DIFFERENTIAL IMMUNOAFFINITY CHROMATOGRAPHY USING SINGLE-DOMAIN MINI-ANTIBODIES | 2014 |
|
RU2553515C1 |
INFANT FORMULA WITH PROBIOTICS AND MILK FAT GLOBULE MEMBRANE COMPONENTS | 2010 |
|
RU2563355C2 |
APPLICATION OF LACTOFERRIN-CONTAINING NUTRITIONAL COMPOSITIONS FOR STIMULATION OF IMMUNE CELLS | 2011 |
|
RU2575776C2 |
Authors
Dates
2016-04-10—Published
2010-01-28—Filed